Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Model predicting survival in stage I melanoma based on tumor progression.

Clark WH Jr, Elder DE, Guerry D 4th, Braitman LE, Trock BJ, Schultz D, Synnestvedt M, Halpern AC.

J Natl Cancer Inst. 1989 Dec 20;81(24):1893-904.

PMID:
2593166
[PubMed - indexed for MEDLINE]
2.

Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.

Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N.

Cancer. 1996 Apr 1;77(7):1303-10.

PMID:
8608507
[PubMed - indexed for MEDLINE]
3.

Prognostic models in melanoma.

Halpern AC, Schuchter LM.

Semin Oncol. 1997 Feb;24(1 Suppl 4):S2-7.

PMID:
9122730
[PubMed - indexed for MEDLINE]
4.

Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.

Barnhill RL, Fine JA, Roush GC, Berwick M.

Cancer. 1996 Aug 1;78(3):427-32. Erratum in: Cancer 1997 Jan 15;79(2):423.

PMID:
8697387
[PubMed - indexed for MEDLINE]
5.

Further validation of the prognostic model for stage I malignant melanoma based on tumor progression.

Szymik B, Woosley JT.

J Cutan Pathol. 1993 Feb;20(1):50-3.

PMID:
8468417
[PubMed - indexed for MEDLINE]
6.

A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group.

Schuchter L, Schultz DJ, Synnestvedt M, Trock BJ, Guerry D, Elder DE, Elenitsas R, Clark WH, Halpern AC.

Ann Intern Med. 1996 Sep 1;125(5):369-75.

PMID:
8702087
[PubMed - indexed for MEDLINE]
7.

Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.

Gimotty PA, Van Belle P, Elder DE, Murry T, Montone KT, Xu X, Hotz S, Raines S, Ming ME, Wahl P, Guerry D.

J Clin Oncol. 2005 Nov 1;23(31):8048-56.

PMID:
16258103
[PubMed - indexed for MEDLINE]
Free Article
8.

Tumor progression, early diagnosis and prognosis of melanoma.

Elder D.

Acta Oncol. 1999;38(5):535-47. Review.

PMID:
10427941
[PubMed - indexed for MEDLINE]
9.

Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase.

Bedrosian I, Faries MB, Guerry D 4th, Elenitsas R, Schuchter L, Mick R, Spitz FR, Bucky LP, Alavi A, Elder DE, Fraker DL, Czerniecki BJ.

Ann Surg Oncol. 2000 May;7(4):262-7.

PMID:
10819365
[PubMed - indexed for MEDLINE]
10.

A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease.

Day CL Jr, Sober AJ, Kopf AW, Lew RA, Mihm MC Jr, Hennessey P, Golomb FM, Harris MN, Gumport SL, Raker JW, Malt RA, Cosimi AB, Wood WC, Roses DF, Gorstein F, Postel A, Grier WR, Mintzis MN, Fitzpatrick TB.

Ann Surg. 1981 Apr;193(4):436-40.

PMID:
7212806
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.

Sahin S, Rao B, Kopf AW, Lee E, Rigel DS, Nossa R, Rahman IJ, Wortzel H, Marghoob AA, Bart RS.

Cancer. 1997 Oct 15;80(8):1426-31.

PMID:
9338466
[PubMed - indexed for MEDLINE]
12.

Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.

Thörn M, Pontén F, Bergström R, Sparén P, Adami HO.

J Natl Cancer Inst. 1994 May 18;86(10):761-9.

PMID:
8169974
[PubMed - indexed for MEDLINE]
13.

Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.

Kruper LL, Spitz FR, Czerniecki BJ, Fraker DL, Blackwood-Chirchir A, Ming ME, Elder DE, Elenitsas R, Guerry D, Gimotty PA.

Cancer. 2006 Nov 15;107(10):2436-45.

PMID:
17058288
[PubMed - indexed for MEDLINE]
Free Article
14.

Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent.

Guerry D 4th, Synnestvedt M, Elder DE, Schultz D.

J Invest Dermatol. 1993 Mar;100(3):342S-345S.

PMID:
8440920
[PubMed - indexed for MEDLINE]
15.

The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up.

Francken AB, Shaw HM, Thompson JF, Soong SJ, Accortt NA, Azzola MF, Scolyer RA, Milton GW, McCarthy WH, Colman MH, McGovern VJ.

Ann Surg Oncol. 2004 Apr;11(4):426-33. Epub 2004 Mar 15.

PMID:
15070604
[PubMed - indexed for MEDLINE]
16.

Independent prognostic importance of vascular invasion in nodular melanomas.

Straume O, Akslen LA.

Cancer. 1996 Sep 15;78(6):1211-9.

PMID:
8826942
[PubMed - indexed for MEDLINE]
17.

Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model.

Tuthill RJ, Unger JM, Liu PY, Flaherty LE, Sondak VK; Southwest Oncology Group.

Am J Clin Pathol. 2002 Oct;118(4):504-11.

PMID:
12375635
[PubMed - indexed for MEDLINE]
Free Article
18.

Thin cutaneous malignant melanomas (< or =1.5 mm): identification of risk factors indicative of progression.

Massi D, Franchi A, Borgognoni L, Reali UM, Santucci M.

Cancer. 1999 Mar 1;85(5):1067-76.

PMID:
10091790
[PubMed - indexed for MEDLINE]
19.

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu PY, Lyman GH, Morabito A.

J Clin Oncol. 2001 Aug 15;19(16):3622-34.

PMID:
11504744
[PubMed - indexed for MEDLINE]
Free Article
20.

A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.

Clark WH Jr, Elder DE, Guerry D 4th, Epstein MN, Greene MH, Van Horn M.

Hum Pathol. 1984 Dec;15(12):1147-65.

PMID:
6500548
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk